Lung Cancer Trial, Not Yet Recruiting NCT07060950 Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07060950
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have a suspected or confirmed invasive tumour, regardless of where it is in the body or how advanced it is.
  • People who are 18 years of age or older.
  • People who have given their informed, written, and explicit consent to take part.
  • People who are enrolled in the French Social Protection System.
  • If a tumour biopsy is involved: the tumour must be considered reachable by biopsy, blood clotting results must be normal, and the person must not be taking blood thinners or anti-clotting medications at the time of the biopsy.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant or currently breastfeeding.
  • People for whom regular follow-up appointments would not be possible due to psychological, family, social, or geographical reasons.
  • People who are detained or who are under legal guardianship.
  • People who have had another invasive cancer in the 5 years before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 467613102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 July 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

All Cohorts : Study of the feasibility of detecting and/or analysing blood or tissue tumour biomarkers.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov